Literature DB >> 1348441

High purity factor VIII concentrates and HIV infection.

C A Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348441      PMCID: PMC1881351          DOI: 10.1136/bmj.304.6827.641

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Genomic imprinting in an Angelman and Prader-Willi translocation family.

Authors:  M Hultén; S Armstrong; P Challinor; C Gould; G Hardy; P Leedham; T Lee; C McKeown
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

2.  High potency factor VIII concentrates.

Authors:  E E Mayne
Journal:  BMJ       Date:  1992-02-01

3.  High potency factor VIII concentrates: value not proved?

Authors:  J D Cash
Journal:  BMJ       Date:  1991-09-14

4.  Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapy.

Authors:  C R Hay; Y Laurian; F Verroust; F E Preston; P B Kernoff
Journal:  Blood       Date:  1990-09-01       Impact factor: 22.113

5.  Serial CD4 lymphocyte counts and development of AIDS.

Authors:  A N Phillips; C A Lee; J Elford; G Janossy; A Timms; M Bofill; P B Kernoff
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

6.  Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

Authors:  C A Lee; A N Phillips; J Elford; G Janossy; P Griffiths; P Kernoff
Journal:  BMJ       Date:  1991-11-02

7.  The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate.

Authors:  R de Biasi; A Rocino; E Miraglia; L Mastrullo; A A Quirino
Journal:  Blood       Date:  1991-10-15       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.